Scott Hutton

Vorstandsvorsitzender bei BIODESIX, INC.

Vermögen: 1 Mio $ am 30.06.2026

54 Jahre

68 Beziehungen

Health Technology

Commercial Services

Health Services

Profil

Scott Hutton is currently President, Chief Executive Officer & Director at Biodesix, Inc. since 2020.
Mr. Hutton serves as Independent Director at Eximis Surgical, Inc. since 2018.
Mr. Hutton is Director & Secretary at The Coalition for 21st Century Medicine.
Mr. Hutton is a Member of Sigma Chi Corp., Purdue Delta Delta Chapter.
Formerly, Mr. Hutton was Director at Colorado BioScience Association from 2011 to 2013.
Mr. Hutton was Senior VP & GM-Vascular Intervention Division at Spectranetics LLC in 2017.
Mr. Hutton was Vice President & General Manager at Medtronic Plc.
Mr. Hutton completed undergraduate education at Purdue University.

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
BIODESIX, INC. 0,62 %	04.03.2026	49 650 ( 0,62 % )	1 Mio $	30.06.2026

Aktive Positionen von Scott Hutton

Unternehmen	Position	Beginn
BIODESIX, INC.	Vorstandsvorsitzender	01.01.2020
Eximis Surgical, Inc. Eximis Surgical, Inc. Medical SpecialtiesHealth Technology Develops and manufactures surgical devices	Direktor/Vorstandsmitglied	01.02.2018
Sigma Chi Corp. Sigma Chi Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a social fraternity	Corporate Officer/Principal	-
The Coalition for 21st Century Medicine The Coalition for 21st Century Medicine Miscellaneous Commercial ServicesCommercial Services The Coalition for 21st Century Medicine is a collaborative organization representing diagnostic technology companies, clinical laboratories, researchers, physicians, venture capitalists, and patient advocacy groups. The non-profit company is based in Arlington, VA. It is dedicated to advancing the development, commercialization, and adoption of molecular and genomic diagnostic technologies that enable personalized medicine, improve patient outcomes, and reduce healthcare costs. The coalition engages with policymakers to shape regulatory, reimbursement, and intellectual property policies supporting innovation in diagnostic medicine, advocates for balanced regulatory frameworks, opposes burdensome regulations on laboratory-developed tests, and promotes patent predictability. It addresses issues such as patent eligibility, Medicare payment modernization, and expanded coverage for advanced diagnostic assays, and regularly submits comments, position statements, and amicus briefs to protect intellectual property rights and improve patient access. The company was founded by Howard C. Birndorf, Jeffrey N. Peterson, M. Kathleen Behrens Wilsey, Patrick F. Terry.	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Scott Hutton

Ehemalige bekannte Positionen von Scott Hutton

Unternehmen	Position	Ende
SPECTRANETICS CORP	Corporate Officer/Principal	01.12.2017
Colorado BioScience Association Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Operates as a association for life sciences	Direktor/Vorstandsmitglied	01.04.2013
MEDTRONIC PLC	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Scott Hutton im Detail an

Ausbildung von Scott Hutton

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Scott Hutton im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	8
Spectranetics LLC Spectranetics LLC Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices for cardiovascular surgeries	Health Technology
Biodesix, Inc. Biodesix, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic research and clinical trial testing services & engages in discovery, development and commercialization of therapeutics	Health Services
Purdue University Purdue University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sigma Chi Corp. Sigma Chi Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a social fraternity	Commercial Services
Colorado BioScience Association Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Operates as a association for life sciences	Commercial Services
The Coalition for 21st Century Medicine The Coalition for 21st Century Medicine Miscellaneous Commercial ServicesCommercial Services The Coalition for 21st Century Medicine is a collaborative organization representing diagnostic technology companies, clinical laboratories, researchers, physicians, venture capitalists, and patient advocacy groups. The non-profit company is based in Arlington, VA. It is dedicated to advancing the development, commercialization, and adoption of molecular and genomic diagnostic technologies that enable personalized medicine, improve patient outcomes, and reduce healthcare costs. The coalition engages with policymakers to shape regulatory, reimbursement, and intellectual property policies supporting innovation in diagnostic medicine, advocates for balanced regulatory frameworks, opposes burdensome regulations on laboratory-developed tests, and promotes patent predictability. It addresses issues such as patent eligibility, Medicare payment modernization, and expanded coverage for advanced diagnostic assays, and regularly submits comments, position statements, and amicus briefs to protect intellectual property rights and improve patient access. The company was founded by Howard C. Birndorf, Jeffrey N. Peterson, M. Kathleen Behrens Wilsey, Patrick F. Terry.	Commercial Services
Medtronic Plc Medtronic Plc Medical SpecialtiesHealth Technology Provides medical technology services	Health Technology
Eximis Surgical, Inc. Eximis Surgical, Inc. Medical SpecialtiesHealth Technology Develops and manufactures surgical devices	Health Technology